retatrutide phase 2 trial

retatrutide phase 2 trial obesity triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in Retatrutide, a TRIPLE agonist (GLP1,

Name: retatrutide phase 2 trial obesity triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in Retatrutide, a TRIPLE agonist (GLP1,
Brand: www.himachallive.in
SKU: 32519475400
Price: 26.16 USD
Availability: InStock
Rating: 4.864000000000001 (28 reviews)

SKU: 32519475400

4.9

USD26.16 USD53.16

Pay in 4 interest-free payments of $6.54 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

287 , C1238C1245 (2004)

What we can assess: For a cost-effectiveness perspective, a published analysis found tirzepatide to be the most cost-effective option compared to oral semaglutide, with an incremental cost-effectiveness ratio of $34,212 per QALY gained